Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine with or without prednisolone for idiopathic membranous nephropathy with nephrotic syndrome
ACTRN12609000996268Phase 4Completed
- Sponsor
- Research Group for Treatments of Kidney Diseases in Ibaraki
- Start
- Jun 2000
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of cyclosporine and prednisolone in idiopathic membranous glomerulonephritis (IMG) (2 arms), sponsored by Research Group for Treatments of Kidney Diseases in Ibaraki. Primary endpoint: Rate of complete remission or partial remission and rate of relapse or recurrence. Started Jun 2000; status: completed.
02
Drugs
cyclosporineprednisolone
03
Conditions
idiopathic membranous glomerulonephritis (IMG)
Beyond the preview
Go deeper on ACTRN12609000996268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000996268.